Serum uric acid and AKI: is it time?

Area of Science:

• Nephrology
• Internal Medicine
• Critical Care

Background:

• Acute kidney injury (AKI) is a common and serious complication in hospitalized patients.
• Current pharmacological and interventional therapies for AKI have yielded disappointing results.
• Identifying modifiable risk factors for AKI is crucial for improving patient outcomes.

Purpose of the Study:

• To revisit the role of uric acid as a potential risk factor in the development of AKI.
• To explore both crystal-dependent and non-crystal-dependent mechanisms in hyperuricemia-induced AKI.
• To synthesize existing evidence on the association between serum uric acid levels and AKI.

Main Methods:

• Review of existing clinical studies and literature.
• Analysis of proposed pathogenic mechanisms of hyperuricemia in AKI.
• Examination of the association between serum uric acid levels and AKI incidence across various clinical settings.

Main Results:

• Hyperuricemia is increasingly recognized as a potential risk factor for AKI.
• Both crystal precipitation and non-crystal-mediated pathways contribute to AKI in hyperuricemia.
• Studies consistently report an association between elevated serum uric acid and AKI development.

Conclusions:

• Hyperuricemia represents a significant, potentially modifiable risk factor for AKI.
• Further investigation is warranted to elucidate the precise mechanisms and clinical implications of hyperuricemia in AKI.
• Targeting uric acid levels may offer a novel therapeutic strategy for AKI prevention and management.